In February, the Hong Kong government approved the China-made Kexing Wuhan pneumonia (novel coronavirus disease, COVID-19) vaccine as a matter of urgency in the absence of Phase 3 clinical data, but several cases of death after vaccination have been reported. Today, another woman in her 70s who had received the vaccine passed away, becoming the fourth case of death after vaccination in two weeks, and another person was sent to the hospital in critical condition after receiving the vaccine and feeling ill at a subway station.
The Hong Kong government announced last month that it had approved the Chinese-made Coxin vaccine for emergency use in Hong Kong, making it the second vaccine to be officially approved after the German-made BioNTech vaccine, and because 1 million doses of the Coxin vaccine arrived in Hong Kong ahead of schedule, it became the first Wu Lung vaccine administered in Hong Kong.
According to the Stand News, a woman in her 70s died today (11) after receiving the vaccine earlier this month, becoming the fourth case of death after vaccination in two weeks, which was also not confirmed to be related to the vaccine. The patient had been injected with the Kexin vaccine a few days ago.
Recent Comments